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Prevention and early intervention are the most effective ways of
avoiding or minimizing psychological, physical, and financial suffer-
ing from cancer. However, such proactive action requires the ability
to predict the individual’s susceptibility to cancer with a measure of
probability. Of the triad of cancer-causing factors (inherited genomic
susceptibility, environmental factors, and lifestyle factors), the
inherited genomic component may be derivable from the recent
public availability of a large body of whole-genome variation data.
However, genome-wide association studies have so far showed lim-
ited success in predicting the inherited susceptibility to common can-
cers. We present here a multiple classification approach for predicting
individuals’ inherited genomic susceptibility to acquire the most likely
phenotype among a panel of 20 major common cancer types plus
1 “healthy” type by application of a supervised machine-learning
method under competing conditions among the cohorts of the
21 types. This approach suggests that, depending on the pheno-
types of 5,919 individuals of “white” ethnic population in this
study, (i) the portion of the cohort of a cancer type who acquired
the observed type due to mostly inherited genomic susceptibility fac-
tors ranges from about 33 to 88% (or its corollary: the portion due to
mostly environmental and lifestyle factors ranges from 12 to 67%),
and (ii) on an individual level, the method also predicts individuals’
inherited genomic susceptibility to acquire the other types rankedwith
associated probabilities. These probabilities may provide practical
information for individuals, heath professionals, and health policy-
makers related to prevention and/or early intervention of cancer.
genomic/environmental factors | k nearest neighbor method | SNP syntax |
multiple assortment model | cancer risk
Prevention and early diagnosis are the two most effective waysof avoiding or minimizing psychological, physical, and financial
suffering from cancer. However, we have only limited knowledge
of predicting the susceptibility for various common cancers. There
are two broadly defined groups of cancers. Only 5–10% of all
known human cancer types are caused primarily by one or a few
genes or genomic elements inherited from parents [such as breast
invasive carcinoma 1 (BRCA1) and BRCA2 in “hereditary” breast
cancer]). However, most common cancer types (over 90%) are
caused by the accumulation of uninherited (i.e., acquired) somatic
mutations triggered by a complex interaction of three types of
causal elements (1, 2), the cancer triad (Fig. 1): environmental
factors (the factors imposed on individuals from outside), lifestyle
factors (the factors chosen or accepted by individuals), and an
individual’s inherited genomic susceptibility factors (1).
Types of Inherited Genomic Variations
Of the triad, there are no extensive experimental data or methods,
at present, to gather and quantitatively describe the data on an
individual’s environmental and lifestyle history accumulated during
the individual’s life. However, the inherited genomic information
can be experimentally obtained from the variation of the whole-genome
sequences of an individual’s noncancerous “germ-line” cells, which
change little during one’s lifetime. A typical human diploid chro-
mosome contains about 6 billion bp, of which a fraction of 0.1%
[about 4–5 million as of 2015 (3)] of diploid locations show genotypes
occasionally different from those of the “reference” human genome
at an experimentally detectable frequency, and this number is ex-
pected to increase. Among many types of variations inherited from
ancestors, about 90% are of one type of variation, SNPs (single-
nucleotide polymorphisms), caused by mutational events at single-
nucleotide positions that resulted in a single base pair change in
the ancestor’s genomes. The remaining types of variations, such as
insertions and deletions of various lengths, copy number variations,
inversions, and others, are the results of a much smaller number of
mutational events, although they affect more base pairs per event,
and it is more challenging, at present, to accurately determine
experimentally at the whole-genome level. SNPs can be experi-
mentally identified for an individual as genotypes at the SNP loci
spread throughout the entire length of the individual’s genome. It
is assumed that some of these variants are more likely to contain
information about the individual’s inherited traits or susceptibility
for many kinds of phenotypes, including complex diseases, such as
common cancer. Beyond the inherited genomic variations, somatic
cancer cells have additional acquired genomic changes (4) result-
ing from environmental and/or lifestyle factors that are causal to
cancer initiation.
Significance
Prevention and early diagnosis of cancer are the most effective
ways of avoiding psychological, physical, and financial suffer-
ing from cancer. We present a machine-learning method for
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individuals, heath professionals, and health policymakers re-
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For the purpose of predicting the inherited genomic suscepti-
bility for common cancers, we used only the SNP genotype data
obtained from the germ-line cells of cancer patients (most com-
monly from blood leukocytes or nontransformed somatic cells),
because they represent the overwhelming portion of all ancestral
genomic variations. The experimental procedure of SNP data
acquisition is better established than others at present, and the
SNP data descriptors are easier to compare computationally.
Machine Learning
Due to dramatic advances in whole-genome sequencing tech-
nology and array technology, a large amount of inherited germ-
line SNP information from patients with many different cancer
types (4) as well as “healthy” populations (3) became publicly
available in recent years. Such availability provides an opportu-
nity to explore developing computational methods to predict an
individual’s inherited genomic susceptibility for a given cancer
type. In addition, since all cancers share common characteristics,
such as unregulated cancer cell growth, avoidance of programed
cell death, invasion of other normal cells, and others (5), such
availability may allow the susceptibility prediction for one cancer
type under a competing condition with other cancer types using
machine-learning (ML) algorithms (6).
ML algorithms have been developed to build a prediction model
from a training set of a large body of observations (i.e., data-driven
model) to make predictions on a testing set. Many of them have
been shown to be very powerful tools for multiple classification of a
large body of data from complex systems, such as handwritten
numerical digits, written or spoken words, images including human
faces, and others (6). ML methods, thus, are fundamentally dif-
ferent from most genome-wide association studies (GWAS), which
can be considered model-driven data selection: the model is the
hypothetical polygenic model (7), and the data selected are the low
P-valued genotypes from the GWAS (8). This approach has so far
limited successes in predicting disease susceptibility (9, 10).
In applying ML methods to genomic variations, there is a
critically important difference to be recognized in the content
of the data used: for the classification of the complex systems
mentioned above, the content of the data is “complete” for the
description of the systems as, for example, digitized pixels of an
image. However, for the prediction of cancer phenotypes, the
content of the data available is significantly incomplete to describe
the phenotypes, because the data contain only the genomic
variation information and no information about environmental
and lifestyle factors. This incompleteness of the data content
is addressed in Inherited Genomic Factor vs. Environmental/
Lifestyle Factor.
Previous Studies
There have been many studies to predict susceptibilities for com-
plex diseases, such as common cancers, by GWAS of SNPs with
limited success, and the possible reasons for the limited success
have been extensively discussed (reviewed in refs. 9 and 10).
However, in an earlier study, the feasibility of obtaining much
higher susceptibility prediction was shown by using ML algo-
rithms on eight types of cancers plus one “control” type (11). In
this study, four different susceptibility prediction methods were
explored in two steps. First, the genotypes at whole-genome
SNP loci of an individual are described in two different ways: (i)
by an ordered profile of the SNP genotypes and (ii) by an ordered
profile of the “SNP genotype syntaxes” (SNP-Ss), where each
SNP-S is defined as a linked ordered-SNP genotype of a given
length. The former description assumes that each SNP geno-
type is independent of its neighbor SNP genotypes, and the
latter assumes that they may be “linked” beyond what linkage
disequilibrium coefficients (12) suggest. Second, the two descrip-
tors were applied to two different supervised ML algorithms: (i)
k nearest neighbor (kNN) method (13) and (ii) support vector
machine (SVM) method (14). Both algorithms require a minimal
number of variable parameters to be optimized using a training
dataset to find good prediction models for testing datasets, and
thus, it is easier to understand and interpret the results than some
other more powerful ML algorithms, such as artificial neural
network algorithms of various depth and complexities (15). Of the
four sets of results (two descriptors times two algorithms), the best
prediction (66% accuracy on average for the training set) for the
inherited genomic susceptibility was achieved by using the kNN
method on the ordered profiles of SNP-Ss and the next best pre-
diction (62% on average) by using the SVM method on the or-
dered profiles of SNP genotypes. In both cases, although the
validation of the prediction model could be tested on the training
dataset, it was not possible to assemble most of the testing sets for
all nine phenotypes, because the cohort size available in the public
databases at the time of the study was not large enough.
Objective of This Study
Since our feasibility study (11), the numbers of cancer types and
cohort sizes in The Cancer Genome Atlas (TCGA) database (4)
have increased substantially, such that we now can improve and
optimize the prediction model using a sufficient number of testing
sets for 20 major cancer types, which account for most of the
common cancer occurrences in the United States (16). Two specific
objectives of this study are (i) to estimate the relative proportion of
a cancer cohort who acquired cancer primarily by the inherited
genomic susceptibility for the cancer (or its corollary: the pro-
portion due to uninherited factors; i.e., the combined environ-
mental and lifestyle factors) and (ii) to estimate the rank-ordered
probabilities of an individual’s susceptibilities for one or more
phenotypes. On a practical side, it is hoped that the information of
an individual’s highest susceptibility toward 1 of the 21 phenotypes
(20 cancer types plus 1 control type) may be useful for the indi-
vidual to decide to minimize the cancer risk through environment
and lifestyle improvement if the individual’s inherited genomic
susceptibility for the cancer is predicted low, or to proactively
monitor for early detection and intervention of the cancer to which
the individual is most susceptible if the genomic susceptibility
is predicted high.
Results
Accuracy of an ML Prediction for Inherited Genomic Susceptibility.
The results from the ML method of kNN suggest that, depending
on the phenotypes of 5,919 individuals of “white” ethnic pop-
ulation in this study representing 20 cancer types and one healthy
phenotype, the prediction accuracy for each cohort ranges from
about 33–88% (Fig. S1). Fig. 2 highlights the multiclass prediction
Fig. 1. The cancer triad. A simplified view of interactions among three
factors (inherited genomic susceptibility, environmental, and lifestyle factors)
that cause somatic mutations and epigenetic modifications of an individual’s
genome to initiate cancer.
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for the cohorts of two cancer types: (i) pheochromocytoma and
paraganglioma (PCPG) and (ii) lung squamous cell carcinoma
(LUSC), corresponding to the highest (88%) and median (44%)
prediction accuracies of the 21 phenotypes. The signal-to-noise
(S/N) ratio for LUSC (Fig. 2B), the ratio of the correct prediction
[“positive call” (PC)] to the wrong prediction (the average of “false
positives”), is 10-fold (44 of 4.3). The predictions and S/N ratios for
all 21 phenotypes are shown for comparative purposes in Fig. S1.
These prediction accuracies are significantly higher than those
predicted for single cancer prediction for a given population by
P value-based GWAS for common SNPs (see Comparison of Multiple
Allele Assortment Model vs. PolyGenic Model). Receiver operating
characteristic curve (17), derived for the kNN model of the mul-
ticlass prediction for the inherited genomic susceptibility using one
vs. all approach, shows a reasonably good prediction performance
of the method (Fig. S2).
Inherited Genomic Factor vs. Environmental/Lifestyle Factor. Fig. 2B
shows, as an example, the average prediction accuracy for the
testing sets of LUSC, each consisting of 40 samples not used in
the training process, obtained from the optimized kNN pre-
diction model (see Parameter Optimization). The tallest white
solid bar in Fig. 2B represents the correct LUSC prediction (PC),
meaning that 44% of the testing cohort with LUSC (indicated by
LUSC on the x axis) is predicted correctly (indicated as LUSC
prediction) by the model to be susceptible for the LUSC cancer.
Since our testing data contain only the genotype information but
do not contain any environmental or lifestyle information, the
PC (44%) corresponds to the percentage of the testing cohort of
LUSC who acquired LUSC by mostly genomic components of
the cancer triad. Thus, the negative calls (56%; the dotted por-
tion above the PC bar in Fig. 2B) can be interpreted as (i) an
error due to the “missed” prediction for LUSC by the model, (ii)
the portion of the LUSC test cohort who acquired the cancer
mostly from nongenomic factors of environment and lifestyle
that are absent from the data, or (iii) a combination of i and ii.
Since the model error for LUSC prediction is small (4.3%),
corresponding to the average of the false positives, interpretation
ii is likely to be correct (i.e., the negative call of LUSC prediction
in Fig. 2B corresponds mostly to the fraction of the LUSC cohort
who acquired LUSC due to nongenomic factors of environment
and lifestyle). Extending this interpretation to all 21 phenotypes,
Fig. 3 emphasizes that the cohort of each phenotype can be di-
vided into two groups and that the relative fraction of the cohort
who may have acquired the respective phenotype mostly by
inherited genomic factors (G group) can be distinguished from
those by environmental and/or lifestyle factors (L/E group). The
unusually high accuracy for PCPG may be due to the high fa-
milial occurrence of pheochromocytoma or paraganglioma ob-
served among the cohort of the phenotype (18) (see Correlation
Between kNN Predictions and Known Observations).
Summarizing the interpretations for all 21 phenotypes, Fig. 3
and Fig. S1 show that, depending on the phenotype, (i) the G
group ranges from 33 to 88% of the respective cohort, (ii) the
ratio of the correct prediction to wrong prediction ranges from
17- to 40-fold, and (iii) the remaining portion of each cohort
(67–12%) may have acquired the respective phenotype mostly by
uninherited (environmental and/or lifestyle) factors.
Cohort Probability vs. Individual Probability. The percentages in
previous sections refer to the population probabilities, the per-
centages of a given cohort who acquired the corresponding phe-
notype mostly by inherited factors or environment/lifestyle factors.
They do not represent the individual probabilities, the probabili-
ties of acquiring the most likely phenotype and other phenotypes
for an individual. These probabilities can be estimated from the
phenotypes of 10 nearest neighbors (see Parameter Optimization) of
the individual, which can range from 100%, when all 10 nearest
neighbors have the same phenotype, to lower, when minority
neighbors have other phenotypes, thus providing ranked probabilities
of acquiring various phenotypes, including the most likely phenotype,
for the individual. For example, the G group of PCPG in Fig. 3
represents that 88% of the PCPG testing cohort is predicted to be
most susceptible to PCPG among the 21 phenotypes. In addition, for
each individual in the G group, we can also predict what other pheno-
types the person is susceptible to with what probability. For example,
Fig. 4A shows that, for the individual with the median probability for
PCPG prediction accuracy among those in the G group of the PCPG
training cohort, there are only three phenotypes found among 10
nearest neighbors as the most likely ones (PCs): eight of them (80%)
with PCPG and 10% each for prostate adenocarcinoma (PRAD)
and brain lower-grade glioma (LGG) (abbreviations are the same
as in Fig. 3). Our analysis provides not only the statistics for each
cohort with the most susceptible phenotype, but also, for each
individual in a cohort, the ranked probabilities of acquiring various
phenotypes other than the most likely phenotype when they are
normalized by the prevalence of respective phenotypes.
“Multiple Allele Assortment Model” of Inherited Susceptibility for
Common Cancers. Identifying the portion of the cohort of LUSC
as PCs (Fig. 2B) that corresponds to the G group who acquired
the phenotype primarily by their inherited genomic factors pro-
vides an opportunity to analyze the population structure within
this portion of the cohort. For all G groups of 21 cohorts com-
bined, our analysis consists of two steps. Since each individual is
described by a vast dimensional vector of SNP-Ss, we first reduce
the dimensionality by the principal component analysis (PCA)
method (Selection of Study Cohorts, SNP Loci, and Genotype
Conversion). Then, we use an unsupervised clustering algorithm,
t-distributed stochastic neighbor embedding (t-SNE) (19), to
cluster all populations of the PCs (i.e., the individuals in the G
groups of the 21 testing cohorts together) (see Inherited Genomic
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Fig. 2. The prediction of the inherited genomic susceptibility for two cancer
types (A) PCPG and (B) LUSC, corresponding to the highest (87.5%) andmedian
(44.0%) prediction accuracies among the 21 phenotypes. The top of the panel
indicates the predicted phenotype, and the x axis lists all of the observed
(“ground truth”) phenotypes of testing sets. (B) For example, the testing
samples of the LUSC cohort show that 44% of testing samples with the LUSC
phenotype (ground truth) are predicted correctly as having acquired LUSC
[positive call (PC) or true positive (TP) call as the white bar] and that 56%
missed prediction of LUSC [negative call or false negative (FN) call as the
dotted bar; negative call is defined here for the LUSC testing samples not
predicted as having LUSC phenotype by the kNN model]. All of the gray bars
are false positives (defined as non-LUSC testing samples predicted to have
LUSC phenotypes), with an average false prediction rate (“average error”) of
4.3%, thus giving the S/N ratio of about 10-fold (44 of 4.3) for the PC. The SD
for the multiple testing sets is shown as the T on the top of each bar (for the
number of testing sets for each phenotype) (Table S1). The interpretation of
negative call marked by the dotted bar is in Inherited Genomic Factor vs.
Environmental/Lifestyle Factor. FP, false positive.
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Factor vs. Environmental/Lifestyle Factor). Fig. 5 shows unsupervised
clustering of all of the G group members predicted by our kNN
method for the 21 phenotype testing cohorts, but for visual simplicity,
only 3 cancer types (PCPG, LUSC, and THCA) of 21 types are made
visible. For these three cancer types, each cancer type consists of
multiple clusters of individuals, each represented by many different
kinds of “features,” which are SNP-Ss in this study. Furthermore,
some SNP-Ss are present in one cluster but not in other clusters in
the same cancer type. This observation reveals a need for a funda-
mentally different concept to predict the inherited susceptibility than
that of the polygenic model (7) used in most GWAS (see Comparison
of Multiple Allele Assortment Model vs. PolyGenic Model).
Discussion
Comparison of the Multiple Allele Assortment Model vs. the PolyGenic
Model. Many GWAS have been performed to predict inherited
cancer susceptibility with limited success (9, 10). Of these, BRCA
has been one of the most studied cancers by GWAS. For example, a
multiplicative polygenic model (7) applied on 76 BRCA-associated
SNP genotypes showed 15% prediction accuracy (10) compared
with 37% in this study (Fig. S1). In general, there are two major
differences in the processes and results between GWAS and kNN.
(i) All GWAS have been performed for a binary prediction between
case and control for each cancer phenotype separately, while in our
kNN approach, the prediction was made by a multitype classifica-
tion process under competing conditions of 20 major cancer types
sharing common basic mechanisms of cancer and 1 control type. (ii)
In the GWAS, the prediction of the inherited susceptibility was
made by applying one set of a small number of the P value-selected
genotypes, usually fewer than 100 SNPs, to a single PolyGenic
Model, but in the kNN approach, a very large pool of low-frequency
SNP-Ss (on average, about 80,000) is selected; then, an assortment
of some of them is primarily associated with one of the multiple
clusters and other assortments with other clusters (multiple allele
assortment model) (Fig. 5).
Correlation Between kNN Predictions and Known Observations. As
shown in Fig. S1, the PCPG cohort shows the highest accuracy
for PC prediction (88%), which corresponds to having the largest
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Fig. 3. The relative fraction of the cohort of each phenotype that may have acquired the phenotype mostly by inherited genomic factors (G; in pink) vs. that
by environmental and/or lifestyle factors (L/E; in cyan). TP and FN stand for true positive (positive call) and false negative (negative call), respectively, as in the
Fig. 2 legend. BLCA, bladder urothelial carcinoma; CESC, cervical squamous cell carcinoma and endocervical adenocarcinoma; COAD, colon adenocarcinoma;
EUR, European white population; GBM, glioblastoma multiforme; HNSC, head and neck squamous cell carcinoma; KIRC, kidney renal clear cell carcinoma;
KIRP, kidney renal papillary cell carcinoma; LIHC, liver hepatocellular carcinoma; LUAD, lung adenocarcinoma; OV, ovarian serous cystadenocarcinoma; PAAD,
pancreatic adenocarcinoma; SARC, sarcoma; STAD, stomach adenocarcinoma; UCEC, uterine carcinosarcoma.
PCPG := median
LUAD
(0.5)
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(0.5)
LUSC :> median THCA := median
0.1
A B C
Fig. 4. Individual’s probabilities of susceptibility to various phenotypes. The G
group of PCPG in Fig. 3 represents the individuals in the PCPG testing cohort
who have inherited genomic susceptibility to PCPG as the most likely pheno-
type among the 21 phenotypes. Within the group, each individual has a dif-
ferent degree of probability for the PCPG susceptibility, although all in the
group are predicted to have PCPG as the most likely phenotype to acquire. A
shows the probabilities of predicting PCPG and other phenotypes (for an in-
dividual who has the median probability for PCPG within the group pop-
ulation): 80% of its nearest neighbors have PCPG, and 10% each have PRAD
and LGG. B and C are the probabilities of predicting various phenotypes for a
member of LUSC or THCA cohorts, respectively. In general, these probabilities
come from the phenotypes of the 10 nearest neighbors in each training set,
which can range from 100%, when all nearest neighbors have the same phe-
notype as the predicted phenotype of the testing individual, to lower percentages
when minority neighbors have other phenotypes, thus providing ranked proba-
bilities of acquiring various phenotypes, including the most likely phenotype for
the individual. COAD, colon adenocarcinoma; GBM, glioblastoma multiforme;
HNSC, head and neck squamous cell carcinoma; LUAD, lung adenocarcinoma.
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G group (Fig. 3) (i.e., the most PCPG cohort acquired PCPG by
inherited genomic factors). This prediction is consistent with the
observation that the PCPG cohort has a very high familial oc-
currence, suggesting a high inherited genomic susceptibility for
PCPG. The germ-line pathogenic mutation of 1 of 14 genes so
far discovered accounts for about 30–40% of PCPG, and the
mutations in these genes are mostly inherited in autosomal
dominant fashion (18). Most likely, more pathogenic genes will
be discovered in the future.
Another interesting observation is about inherited vs. somat-
ically altered BRCAmutants (a subject not covered in this study).
Since the BRCA phenotype has one of the largest cohorts in
TCGA database of common cancers, it provides an opportunity
to inquire about the contribution of these genes toward acquiring
common BRCA, which is caused by the mutation of many genes
of low penetrance. An examination of the exom sequence data of
the BRCA cohort in TCGA reveals that, of our test set of 200
common BRCA cohorts, only 10 members (5% of the cohort)
have somatic mutations of BRCA-1/2 genes of mostly unidentified
penetrance, which agrees with the lower bound of an earlier ob-
servation of 5–10% for all breast cancers (20). This observation
suggests that, although the pathogenic BRCA-1 or -2 genes have
been found to have high penetrance for BRCA and account for
20–25% of inherited BRCA, these somatic mutations participate
(in collaboration with the mutations of many other genes or genomic
elements as expected for a common cancer) in initiating common
BRCA only in a very small fraction of the cohort. Furthermore, of
the 10 members, 8 members belong to the “E/L group” (the sub-
cohort that acquired BRCA mostly due to environmental/lifestyle
factors) of the BRCA testing cohort, suggesting that environmental
and lifestyle factors had more influence in triggering somatic
BRCA-1/2 mutations for this subgroup than inherited genomic
factors, information useful for the close relatives of the carriers
of the somatic mutants of BRCA genes. The multiple allele assortment
model (see “Multiple Allele Assortment Model” for Inherited Sus-
ceptibility for Common Cancers) can provide possible explana-
tions for both observations.
A similar interpretation can be made for the role of so-
matic mutations of BRCA-1/2 in the common ovarian serous
cystadenocarcinoma.
Population Structure of the Sample. Population stratification of
genomic variations is implicated in the polymorphic genotype
variants as well as the number of variants among 26 geographic
populations of the world, suggesting the presence of systematic
difference in the variant alleles between the subpopulations in
the human population, possibly due to different ancestry (21). To
minimize the effect of such stratification in our study, we se-
lected our study samples under the following four considerations.
(i) We selected only the samples self-reported as white under the
race classification category in TCGA, which account for the
majority of TCGA data. (ii) Since self-reporting of race classi-
fication is not always reliable, we used PCA on all samples of the
white population and removed about 14% of the samples as
“outliers” (Fig. S5 A and B). (iii) The PCA-selected samples
(86%) were subjected to a second PCA to see if there is any
significant correlation between geographical populations and
cancer types. Comparison in Fig. S5 C and D shows that the
geographical populations segregate reasonably well by the sec-
ond PCA (Fig. S5C), but cohorts of different phenotypes do not
cluster but are distributed broadly on the same PCA plot space
(Fig. S5D): two different coloring schemes (for geographical groups
and cancer phenotype groups) show no significant correlation be-
tween ethnic group identity and the 21 phenotypes as revealed by
the distinctly different distribution pattern of each population as
well as the positions of the medians of the groups of phenotypes
and those of ethnic groups. (iv) Finally, we optimized the param-
eters of the descriptor, SNP-Ss of individual genomic variations,
that provides the description of the variation sensitive to the cancer
type but not any other factors, such as ancestry, geography, etc.
(see Parameter Optimization). Similar types of analysis can be easily
performed after a large body of genomic variation data becomes
available for any ethnic/geographic population or a collection of
related such populations.
Systematic Bias Among Datasets of Different Phenotypes. Although
all datasets used in this study were obtained from the same
genotyping microarray platform, there may be some variations in
experimental biases among the datasets of different phenotypes
that could influence the training process of the kNN model and
thus, the prediction accuracy. The curated data used in this study
(Selection of Study Cohorts, SNP Loci, and Genotype Conversion)
do not seem to have significant bias as indicated by the relatively
small differences between the training and testing accuracies for
all of the phenotype datasets, except for the cervical squamous
cell carcinoma and European white population datasets, which
have slightly larger differences than the average (Fig. S3).
Sample Size and Ethnic Diversity. It is surprising that the training
sample size as small as 100 for each phenotype could produce a
model that can clearly predict the most likely phenotype to which
an individual is susceptible with an S/N ratio ranging from 9- to
40-fold (Fig. 3 and Fig. S1). However, it is noticeable that some
of the SDs of the predictions, when more than one testing sample
is available, are relatively high, ranging from a few to 10% (Fig.
S1), as expected for only 100 samples per training set. They are
expected to improve as the sample size and diversity for each
cohort increase in future studies. As for the applicability of the
method to other ethnic populations, similar studies are needed
when sufficient data for “nonwhite” ethnic populations become
available in future.
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Fig. 5. Unsupervised clustering of the PCs shown in Fig. S1 by the tsne
program package, which has an implementation of t-SNE (19) in R. For visual
simplicity, only 3 cancer types, PCPG, LUSC, and THCA, of 21 types used in the
clustering are made visible to illustrate the multiple allele assortment model
for cancer susceptibility. There are multiple clusters, each represented by a
different assortment of SNP-S features. For PCPG, which shows the highest
prediction accuracy, there are only two dense and tight clusters that account
for about 69% of the PCs of the combined set of training and testing, and
the rest (31%) form many loose small clusters. However, about 46% of LUSC
PCs form four dense and small clusters, and the rest (54%) form many small
loose clusters.
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Data Source of the Germ-Line SNP Genotypes. Thirty-four germ-line (from
leukocytes and/or untransformed normal solid tissues) SNP datasets from
TCGA (deposited in February 2015) were downloaded with approval. Data
downloaded were all at level 2. For the genotypes of control phenotypes, we
used those from The 1000 Genome (G1K) Project (3), which used Affymetrix
Genome-Wide Human SNP (GHS) Array 6.0 (which is designed to determine
about 1 million “tag” SNP genotypes), the same as that used by all 20 groups
of TCGA data that we selected for our study (Selection of Study Cohorts,
SNP Loci, and Genotype Conversion). The genotypes were converted for
achieving strand consistency (22) between TCGA and G1K Project data by
using GHS Array 6.0 Netaffx release 35 annotation.
Selection of Study Cohorts, SNP Loci, and Genotype Conversion. Of 34 TCGA
datasets, we chose the SNP genotype data for 20 cancer phenotypes for which
the cohort size is equal to or greater than 180 individuals. A summary of data
selection is shown in Table S1. In the selection process, we removed those
samples that are duplicated and have third degree kinship (23), selected self-
reported white individuals under the race classification category, and re-
moved outliers based on PCA (24, 25). For the control group from the G1K
Project data, we chose the samples from five countries: Utah residents with
northern and western European ancestries, British in England and Scotland,
Toscani in Italy, Finnish in Finland, and Iberian population. The total sample
size used for our study was 5,919 individuals. As for the SNP loci selected for
the study of 906,600 SNP loci designed to probe in the Affymtrix GHS Array
6.0, 868,023 loci were selected for autosomal SNP loci. We further excluded
the loci having Hardy–Weinberg equilibrium test P value < 1.0e-6 and ge-
notype inconsistency ratio >1% between reported G1K Project genotypes (3)
and genotypes called by Affymetrix Power Tools with default parameters to
arrive at the final 818,278 SNP loci, for which all experimentally determined
SNP genotypes were downloaded.
Training Set and Testing Sets. The training set contains 2,100 samples, the sum
of 100 randomly selected individuals from each of 21 phenotype cohorts. For
testing sets for each phenotype, the remaining cohorts that were not selected
for training set were divided into multiple, nonoverlapping testing sets of
40 individuals each (Table S1). The training set was used to train the kNN
model (kNN Method). The contingency table for the training performance,
which reveals the validation of the prediction model for the training set, is
shown in Table S2, and that for the testing sets is shown in Table S3. The
difference between training performance and testing performance is small,
in general, as shown in Fig. S3, which validates that the extent of “over-
fitting” the training data is relatively small; thus, the training sample size is
large and random enough to produce a reasonably good prediction model
for the size of the testing set.
kNN Method. The details of the application of the kNN method for this study
have been published in our feasibility study (11). Conceptually, all training
samples (individuals) from 21 phenotypes occupy different positions in a
very high-dimensional space (818,278 dimensions), where the position of
each sample is described by its high-dimensional vector of ordered SNP-Ss.
Then, the method assumes that, for an individual, the majority of its k
nearest neighbors has the same phenotype as that of the individual. The
optimal parameter k is empirically determined by using all of the training set
(Parameter Optimization). The nearest neighbors are selected by the distance
between the testing sample and all of the training samples, where the dis-
tance between two multidimensional vectors is calculated by Jensen–Shannon
Divergence (26). Each vector containing the genomic variation information of
an individual is described below in SNP-S.
Parameter Optimization. Using the data of the training set consisting of
100 samples for each phenotype (Training Set and Testing Sets), the optimal
parameters are (i) the length of SNP-Ss (SNP-S) l; (ii) the frequency limit f,
where the rarest SNP-S among all cohorts has its frequency of f or below;
and (iii) the number of nearest neighbors k, where the majority of the kNNs
has the correct phenotype for the testing individual and gives the best
classification among the 21 phenotypes. The result of simultaneous opti-
mization of the three parameters is shown in Fig. S2, where the optimal
parameters are empirically determined to be: l = 8 SNP genotypes, f = 1%
frequency, and k = 10 nearest neighbors. In the training process to find the
best parameters, we used the training set of data of all 21 groups. For
testing, each individual of the testing sets is applied to the kNN model (kNN
Method) to find predicted phenotype.
SNP-S. Another assumption that we made is that each SNP locus used in this
study may not be independent but linked to its neighbor loci to an unknown
extent beyond what the linkage disequilibrium coefficient (12) suggests.
Thus, we replace each SNP genotype with an SNP-S, which is simply a string
of eight ordered SNP genotypes starting with the starting SNP genotype,
where the number eight was empirically determined by optimization to get
the best classification of 21 phenotypes by multiclass classification in kNN
(kNN Method).
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